Copyright
©The Author(s) 2017.
World J Gastroenterol. Apr 14, 2017; 23(14): 2519-2526
Published online Apr 14, 2017. doi: 10.3748/wjg.v23.i14.2519
Published online Apr 14, 2017. doi: 10.3748/wjg.v23.i14.2519
Variables | Number of patients |
Age, median (range) | 66 (20-96) |
Sex | |
Male | 233 |
Female | 79 |
Diabetes mellitus | |
Absent | 273 |
Present | 39 |
Cardiac comorbidities | |
Absent | 217 |
Present | 95 |
Pulmonary comorbidities | |
Absent | 292 |
Present | 20 |
Preoperative symptoms | |
Absent | 172 |
Present | 140 |
Preoperative body mass index, mean ± SD | 21.9 ± 3.2 |
Tumor location | |
Entire | 8 |
Upper third | 68 |
Middle third | 120 |
Lower third | 116 |
Tumor size (mm) | |
< 50 | 176 |
≥ 50 | 136 |
UICC cT factor | |
cT1 | 0 |
cT2 | 150 |
cT3 | 95 |
cT4 | 67 |
UICC cN factor | |
cN0 | 157 |
cN1 | 93 |
cN2 | 53 |
cN3 | 9 |
UICC clinical stage | |
IB | 98 |
IIA | 71 |
IIB | 69 |
IIIA | 55 |
IIIB | 14 |
IIIC | 5 |
- Citation: Inaoka K, Kanda M, Uda H, Tanaka Y, Tanaka C, Kobayashi D, Takami H, Iwata N, Hayashi M, Niwa Y, Yamada S, Fujii T, Sugimoto H, Murotani K, Fujiwara M, Kodera Y. Clinical utility of the platelet-lymphocyte ratio as a predictor of postoperative complications after radical gastrectomy for clinical T2-4 gastric cancer. World J Gastroenterol 2017; 23(14): 2519-2526
- URL: https://www.wjgnet.com/1007-9327/full/v23/i14/2519.htm
- DOI: https://dx.doi.org/10.3748/wjg.v23.i14.2519